Medicare Enrolled
Dr. Thiri Khin, M.D
Student in an Organized Health Care Education/Training Program · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khin
Dr. Thiri Khin is a student in an organized health care education/training program specialist in Anaheim, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Khin performed 2,141 Medicare services across 866 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khin received a total of $7,427 from 70 pharmaceutical and/or device companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 9% volume in CA
$7,427 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,141
Medicare services
Top 9% in CA for student in an organized health care education/training program
866
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~178 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
503 | $101 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
399 | $105 | $200 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
354 | $8 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
352 | $8 | $10 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
149 | $148 | $275 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
104 | $109 | $185 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
86 | $13 | $40 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
80 | $65 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $75 | $150 |
| New patient office visit, complex (60-74 min) | 26 | $186 | $382 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $158 | $260 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
16 | $43 | $91 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,427
Total received (2018-2024)
Avg $1,061/year across 7 years
Top 5% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
344
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,235 (97.4%)
Other
Charitable contributions, space rental, and other categories
$143 (1.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$999
2023
$2,500
2022
$1,328
2021
$1,130
2020
$339
2019
$642
2018
$490
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$154
Novartis Pharmaceuticals Corporation
$143
PFIZER INC.
$91
Gilead Sciences, Inc.
$80
Eisai Inc.
$61
ABBVIE INC.
$52
BeiGene USA, Inc.
$52
Daiichi Sankyo Inc.
$49
Coherus Biosciences Inc.
$44
Janssen Biotech, Inc.
$42
Astellas Pharma US Inc
$34
Tempus AI, Inc
$29
SpringWorks Therapeutics, Inc.
$27
Ipsen Biopharmaceuticals, Inc
$23
PharmaEssentia USA Corporation
$23
AstraZeneca Pharmaceuticals LP
$22
Incyte Corporation
$21
Myriad Genetic Laboratories, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$16
Mirati Therapeutics, Inc.
$15
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$717
AstraZeneca Pharmaceuticals LP
$540
Janssen Biotech, Inc.
$539
Incyte Corporation
$368
PFIZER INC.
$361
Amgen Inc.
$273
Gilead Sciences, Inc.
$251
Novartis Pharmaceuticals Corporation
$239
Genentech USA, Inc.
$202
Daiichi Sankyo Inc.
$182
Astellas Pharma US Inc
$178
Exelixis Inc.
$157
Regeneron Healthcare Solutions, Inc.
$155
E.R. Squibb & Sons, L.L.C.
$147
Bayer Healthcare Pharmaceuticals Inc.
$139
Eisai Inc.
$136
BeiGene USA, Inc.
$134
Merck Sharp & Dohme Corporation
$119
Seagen Inc.
$118
Lilly USA, LLC
$117
GENZYME CORPORATION
$109
Bayer HealthCare Pharmaceuticals Inc.
$105
Coherus Biosciences Inc.
$87
Foundation Medicine, Inc.
$83
AMAG Pharmaceuticals, Inc.
$80
Sumitomo Pharma America, Inc.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
TerSera Therapeutics LLC
$75
PharmaEssentia USA Corporation
$73
Puma Biotechnology, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$71
Acrotech Biopharma LLC
$69
MorphoSys, US Inc.
$65
Merck Sharp & Dohme LLC
$64
Helsinn Therapeutics (U.S.), Inc.
$63
Mirati Therapeutics, Inc.
$59
JAZZ PHARMACEUTICALS INC.
$59
Takeda Pharmaceuticals U.S.A., Inc.
$57
EISAI INC.
$57
AbbVie, Inc.
$56
Myovant Sciences Inc.
$53
ABBVIE INC.
$52
Blueprint Medicines Corporation
$50
Ipsen Biopharmaceuticals, Inc
$50
Karyopharm Therapeutics Inc.
$48
Organon LLC
$45
SOBI, INC
$41
Stemline Therapeutics Inc.
$37
Rigel Pharmaceuticals, Inc.
$36
TAIHO ONCOLOGY, INC.
$36
Taiho Oncology, Inc.
$32
Kite Pharma, Inc.
$30
Tempus AI, Inc
$29
TOLMAR Pharmaceuticals, Inc.
$29
Aveo Pharmaceuticals, Inc.
$28
Pharmacyclics LLC, an AbbVie Company
$27
SpringWorks Therapeutics, Inc.
$27
PUMA BIOTECHNOLOGY, INC.
$25
Agios Pharmaceuticals, Inc.
$23
AbbVie Inc.
$22
Sobi, Inc
$21
Myriad Genetic Laboratories, Inc.
$20
Seattle Genetics, Inc.
$20
Deciphera Pharmaceuticals Inc.
$18
ImmunoGen, Inc.
$18
Epizyme, Inc.,
$17
AVEO Pharmaceuticals, Inc.
$16
GlaxoSmithKline, LLC.
$16
Alexion Pharmaceuticals, Inc.
$14
Clovis Oncology, Inc.
$12
Top 3 companies account for 24.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · AYVAKIT · Alecensa · Avastin · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · Erivedge · FERAHEME · FORTEO · FOTIVDA · FOUNDATIONACT · FOUNDATIONONE · FRUZAQLA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · Rezlidhia · Rubraca · SARCLISA · SOMATULINE DEPOT · SPRYCEL · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for student in an organized health care education/training program in CA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
11,778
Per 100K population
372.2
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khin is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 5% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khin experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Khin performed 503 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khin receive payments from pharmaceutical companies?
Yes. Dr. Khin received a total of $7,427 from 70 companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khin's costs compare to other student in an organized health care education/training programs in Anaheim?
Dr. Khin's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Anaheim
Browse student in an organized health care education/training programs in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in CA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in CA
Which CA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology